Lehmann, F.; Schneider, M.; Bernstock, J.D.; Bode, C.; Borger, V.; Ehrentraut, S.F.; Gessler, F.; Potthoff, A.-L.; Putensen, C.; Schenk, L.M.;
et al. Treatment-Limiting Decisions in Patients with Spontaneous Intracerebral Hemorrhage. Medicina 2022, 58, 989.
https://doi.org/10.3390/medicina58080989
AMA Style
Lehmann F, Schneider M, Bernstock JD, Bode C, Borger V, Ehrentraut SF, Gessler F, Potthoff A-L, Putensen C, Schenk LM,
et al. Treatment-Limiting Decisions in Patients with Spontaneous Intracerebral Hemorrhage. Medicina. 2022; 58(8):989.
https://doi.org/10.3390/medicina58080989
Chicago/Turabian Style
Lehmann, Felix, Matthias Schneider, Joshua D. Bernstock, Christian Bode, Valeri Borger, Stefan Felix Ehrentraut, Florian Gessler, Anna-Laura Potthoff, Christian Putensen, Lorena M. Schenk,
and et al. 2022. "Treatment-Limiting Decisions in Patients with Spontaneous Intracerebral Hemorrhage" Medicina 58, no. 8: 989.
https://doi.org/10.3390/medicina58080989
APA Style
Lehmann, F., Schneider, M., Bernstock, J. D., Bode, C., Borger, V., Ehrentraut, S. F., Gessler, F., Potthoff, A.-L., Putensen, C., Schenk, L. M., Zimmermann, J., Vatter, H., Schuss, P., & Hadjiathanasiou, A.
(2022). Treatment-Limiting Decisions in Patients with Spontaneous Intracerebral Hemorrhage. Medicina, 58(8), 989.
https://doi.org/10.3390/medicina58080989
